SCHEMBL26519682

SCHEMBL26519682

CC1CCOCC12CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22813394 1.00 — —
SCHEMBL17348570 0.91 — —
SCHEMBL15927296 0.91 — —
SCHEMBL16659522 0.83 — —
SCHEMBL16659517 0.79 — —
SCHEMBL16659516 0.78 — —
SCHEMBL23083352 0.78 SLC6A2 (0.38) —
SCHEMBL23083342 0.78 SLC6A2 (0.38) —
SCHEMBL22642378 0.76 HRH3 (0.33) —
SCHEMBL27115295 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339902-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2023-10-26 — — US disclosed
WO-2023192375-A1 HSD17B13 INHIBITORS AND USES THEREOF FL2022-001, INC. (US) 2023-10-05 — — WO disclosed
Send feedback